Nanexa AB (publ) Stock Forecast for 2023 - 2025 - 2030
Updated on 05/03/2024
Nanexa AB (publ) Stock Forecast and Price Target
The average price target for Nanexa AB (publ)'s stock of kr3.40 recently provided by leading analysts would represent a 392.75% upside from its last closing price if reached. This potential increase is based on a high estimate of kr3.50 and a low estimate of kr3.30. If you want to buy NANEXA stock, it might be a good idea to look at its competitors too.
392.75% Upside
Nanexa AB (publ) Fair Value Forecast for 2023 - 2025 - 2030
In the last three years, Nanexa AB (publ)'s Price has grown by 100.00%, rising from kr0.00 to kr0.00. For the next year, analysts predict that Fair Value will reach kr0.73 – an increase of 100.00%. Over the next seven years, experts believe that Nanexa AB (publ)'s Fair Value will grow at a rate of 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SEDANA Stock Forecast | Sedana Medical AB (publ) | Outperform |
7
|
kr22.15 | Buy/Sell | kr43.00 | 60.27% |
| STIL Stock Forecast | Stille AB |
0
|
kr201.00 | Buy/Sell | kr150.00 | 1.00% | |
| ADDV A Stock Forecast | ADDvise Group AB (publ) |
14
|
kr13.90 | Buy/Sell | kr23.00 | 36.69% | |
| BIBB Stock Forecast | BiBBInstruments AB | - |
5
|
kr2.96 | Buy/Sell | kr0.00 | -100.00% |
| ICO Stock Forecast | Iconovo AB (publ) |
0
|
kr8.04 | Buy/Sell | kr37.50 | 161.19% |
Nanexa AB (publ) Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Nanexa AB (publ)'s Revenue has grown by 185.19%, rising from kr20.86M to kr59.49M. According to 0 prominent analysts, Nanexa AB (publ)'s Revenue will fall by 24.07% in the next year, reaching kr45.17M. By 2030, professionals believe that Nanexa AB (publ)'s Revenue will decrease by 32.33%, reaching kr40.26M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GTAB B Stock Forecast | Glycorex Transplantation AB (p... | - |
0
|
kr1.00 | Buy/Sell | kr0.00 | -100.00% |
| ISAB Stock Forecast | Inhalation Sciences Sweden AB ... |
0
|
kr4.34 | Buy/Sell | kr17.00 | 280.18% | |
| HEMC Stock Forecast | Hemcheck Sweden AB (publ) | - |
4
|
kr0.18 | Buy/Sell | kr0.00 | -100.00% |
.jpg)
Nanexa AB (publ) EBITDA Forecast for 2023 - 2025 - 2030
Nanexa AB (publ)'s EBITDA has seen growth In the last three years, going from kr-18.83M to kr-62.80M – a gain of 233.51% In the next year, 1 analysts estimate that Nanexa AB (publ)'s EBITDA will decrease by 106.37%, reaching kr4.00M. According to professional forecasts, in 2030, Nanexa AB (publ)'s EBITDA will decrease by 660.64%, reaching kr352.08M.
Nanexa AB (publ) EBIT Forecast for 2023 - 2025 - 2030
In the last three years, EBIT for Nanexa AB (publ) has grown by 259.77%, going from kr-21.30M to kr-76.63M. According to 2 analysts, Nanexa AB (publ)'s EBIT will fall by 113.70% in the next year, reaching kr10.50M. Professionals believe that By 2030, Nanexa AB (publ)'s EBIT will fall to kr-25.20M – a 67.12% decrease from its current value.
Nanexa AB (publ) EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last three years, Nanexa AB (publ)'s EPS has grown by 100.00%, rising from kr-1.01 to kr0.00. For the next year, analysts predict that EPS will reach kr-0.18 – an increase of 100.00%. Over the next seven years, experts believe that Nanexa AB (publ)'s EPS will grow at a rate of 100.00%.
.jpg)